Arcutis Biotherapeutics, Inc. - Common stock — キャッシュフロー (NASDAQ:ARQT) | MetaTrader

チャート全体を表示 Full chart

Financials

概要明細書統計

営業活動によるキャッシュフロー -113.03 M-174.63 M-257.71 M-247.06 M-112.16 M-5.63 M 26.99 M 投資活動によるキャッシュフロー -181.82 M-75.95 M-87.2 M180.23 M28.82 M-30.25 M -53.34 M 財務活動によるキャッシュフロー 298.14 M281.95 M301.8 M101.32 M66.2 M6.97 M 7.64 M フリーキャッシュフロー -113.03 M-174.63 M-257.71 M-247.06 M-112.16 M-16.31 M 26.92 M

ニュース

Arcutis Biotherapeutics: The Dermatology Platform Is Starting To Compound (NASDAQ:ARQT)

Arcutis Biotherapeutics, Inc. 2026 Q1 - Results - Earnings Call Presentation (NASDAQ:ARQT) 2026-05-07

Arcutis Biotherapeutics, Inc. (ARQT) Reports Q1 Loss, Beats Revenue Estimates

PTC Therapeutics (PTCT) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release

Will Arcutis Biotherapeutics, Inc. (ARQT) Report Negative Earnings Next Week? What You Should Know

Arcutis Biotherapeutics Shows Market Leadership With Jump To 82 RS Rating

PGIM Jennison Health Sciences Fund Q4 2025 Key Contributors And Detractors

Arcutis、幼児向け湿疹クリームの長期データを報告

Arcutis reports long-term data on eczema cream for young children

Arcutis enrolls first patient in ARQ-234 atopic dermatitis trial

Arcutis at TD Cowen Conference: Strategic Growth Insights

みずほ、コスト増加を理由にArcutis株の目標株価を35ドルに引き下げ